News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cubist Pharmaceuticals, Inc. (CBST) Release: Markman Hearing Cancelled in Cubist Pharmaceuticals' Patent Infringement Action Against Teva Parenteral Medicines, Inc. (TEVA)


6/4/2010 9:22:35 AM

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that the U.S. District Court for the District of Delaware notified Cubist that the Markman hearing previously scheduled for June 9, 2010 has been cancelled. The court stated that a claim construction order will issue in due course.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES